Colomer R - Search Results

1

Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer.

Hitt R, Hornedo J, Colomer R, Hidalgo M, Brandariz A, Peña M, Vicent JA, Cortés-Funes H. Hitt R, et al. Among authors: colomer r. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-58-S2-64. Semin Oncol. 1997. PMID: 9045339 Clinical Trial.

2

Mitomycin-C and vinblastine in advanced breast cancer.

Navarro M, Bellmunt J, Balañá C, Colomer R, Jolis L, del Campo JM. Navarro M, et al. Among authors: colomer r. Oncology. 1989;46(3):137-42. doi: 10.1159/000226702. Oncology. 1989. PMID: 2497417 Review.

3

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.

Mayordomo JI, Rivera F, Díaz-Puente MT, Lianes P, Colomer R, López-Brea M, López E, Paz-Ares L, Hitt R, García-Ribas I, et al. Mayordomo JI, et al. Among authors: colomer r. J Natl Cancer Inst. 1995 Jun 7;87(11):803-8. doi: 10.1093/jnci/87.11.803. J Natl Cancer Inst. 1995. PMID: 7540696 Clinical Trial.

4

A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.

Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H. Hitt R, et al. Among authors: colomer r. Semin Oncol. 1995 Dec;22(6 Suppl 15):50-4. Semin Oncol. 1995. PMID: 8643971 Clinical Trial.

5

Recall reaction of a severe local peripheral neuropathy after paclitaxel extravasation.

Hidalgo M, Benito J, Colomer R, Paz-Ares L. Hidalgo M, et al. Among authors: colomer r. J Natl Cancer Inst. 1996 Sep 18;88(18):1320. doi: 10.1093/jnci/88.18.1320-a. J Natl Cancer Inst. 1996. PMID: 8797774 No abstract available.

6

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.

García-Carbonero R, Hidalgo M, Paz-Ares L, Calzas J, Gómez H, Guerra JA, Hitt R, Hornedo J, Colomer R, Cortés-Funes H. García-Carbonero R, et al. Among authors: colomer r. J Clin Oncol. 1997 Oct;15(10):3178-84. doi: 10.1200/JCO.1997.15.10.3178. J Clin Oncol. 1997. PMID: 9336353

7

Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma.

Colomer R, Aparicio J, Montero S, Guzmán C, Larrodera L, Cortés-Funes H. Colomer R, et al. Br J Cancer. 1997;76(9):1215-20. doi: 10.1038/bjc.1997.536. Br J Cancer. 1997. PMID: 9365172 Free PMC article.

8

Paclitaxel plus doxorubicin in metastatic breast cancer: preliminary analysis of cardiotoxicity.

Martin M, Lluch A, Ojeda B, Barnabas A, Colomer R, Massuti B, Benito D. Martin M, et al. Among authors: colomer r. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-26-S17-30. Semin Oncol. 1997. PMID: 9374088 Clinical Trial.

9

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

Hitt R, Paz-Ares L, Hidalgo M, Colomer R, Brandariz A, Peña M, Alvarez-Vicent J, Hornedo J, Cortés-Funes H. Hitt R, et al. Among authors: colomer r. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-20-S19-24. Semin Oncol. 1997. PMID: 9427260 Clinical Trial.

10

Should prophylactic surgery be used in women with a high risk of breast cancer?

Klijn JG, Janin N, Cortés-Funes H, Colomer R. Klijn JG, et al. Among authors: colomer r. Eur J Cancer. 1997 Nov;33(13):2149-59. doi: 10.1016/s0959-8049(97)00360-2. Eur J Cancer. 1997. PMID: 9470800 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters